Concepedia

K. Astamirova

KA

Statistics

Publications

3

Citations

392

H-Index

3

Active since

2018

Affiliations

Novo Nordisk (Denmark)(Current)

Translational Research Institute for Metabolism and Diabetes

K. Astamirova is an author at Novo Nordisk (Denmark) specializing in clinical pharmacology, medicine, and diabetes management.

ORCID

Publications per year

2018–2025

3

Publications

3

Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial

Ofri Mosenzon, Thalia Marie Blicher, Signe Rosenlund et al. · The Lancet Diabetes & Endocrinology · 2019 · 342 citations · Full text

, , +13

Similar glycaemic control with less nocturnal hypoglycaemia in a 38-week trial comparing the IDegAsp co-formulation with insulin glargine U100 and insulin aspart in basal insulin-treated subjects with type 2 diabetes mellitus

Athena Philis‐Tsimikas, K. Astamirova, Yashdeep Gupta et al. · Diabetes Research and Clinical Practice · 2018 · 40 citations · Full text

, , +16

Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis

Peter Rossing, George L. Bakris, Vlado Perkovic et al. · Diabetes Care · 2025 · 10 citations · Full text

, , +15

1–3 of 3